INDENA SPA (Italy) holds 18 active US FDA Type II Drug Master Files and 4 inactive, has DMF or CEP filings on record for 14 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “INDENA SPA: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/indena-spa

Overview

INDENA SPA is an active pharmaceutical ingredient (API) supplier with 17 active FDA Type II Drug Master Files, covering 10-DEACETYLBACCATIN III/R; CABAZITAXEL; CABAZITAXEL ACETONE; CANNABIDIOL; COLCHICINE USP; DOCETAXEL.

Core services & business areas

API ManufacturingPharmaceutical ManufacturingPhytochemical ExtractionCustom ManufacturingRegulatory AffairsResearch and Development

Active ingredients with DMF or CEP filings

Substances for which INDENA SPA holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

INDENA SPA holds 18 active (22 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • MELPHALAN HCL INDENA CODE (3039400)Active2026-09-30
  • CABAZITAXEL ACETONEActive2025-01-27
  • VOCLOSPORINActive2024-10-15
  • TIRBANIBULINActive2024-10-07
  • CANNABIDIOLActive2021-02-16
  • CABAZITAXELActive2020-04-17
  • RESINIFERATOXINActive2020-03-11
  • PACLITAXEL/SWActive2019-10-25
  • THIOTEPAActive2019-05-24
  • DOCETAXEL TRIHYDRATEActive2018-09-28
  • PACLITAXEL/S SEMISYNTHETIC PROCESS, USP/EPActive2013-08-06
  • DOCETAXELActive2010-08-30
  • N-DEBOC-DOCETAXEL (N-DEBENZOYL-10-DEACETYLPACLITAXEL INTERMEDIATE)Active2010-06-08
  • PACLITAXEL/SActive2007-10-22
  • PACLITAXEL P.I.Active2002-11-13
  • 10-DEACETYLBACCATIN III/RActive1993-08-25
  • COLCHICINE USPActive1993-02-10
  • RESERPINE USPActive1983-04-29
  • INGENOL MEBUTATEInactive2014-12-22
  • IDN 5404 (THIOCOLCHICINE DERIVATIVE)Inactive2008-10-29
  • IDN 5109Inactive2002-02-19
  • PACLITAXELInactive1998-02-23

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to INDENA SPA, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to INDENA SPA in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this INDENA SPA?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.